CanFite Biopharma (CANF)
(Delayed Data from AMEX)
$2.01 USD
+0.03 (1.26%)
Updated Apr 22, 2024 11:42 AM ET
3-Hold of 5 3
B Value F Growth A Momentum C VGM
Industry / Sector Report
Industry : Medical - Drugs
Zacks Industry Rank
Top 37% (93 out of 252)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.00 | 1.52 | 9.99 |
Current Quarter Estimate | NA | -2.04 | 60.00 |
Year Ago Quarter Estimate | -0.65 | -0.59 | 52.54 |
Next Quarter Estimate | NA | -2.00 | 61.00 |
Next Year Estimate | NA | 6.92 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 98.32 | 10.20 | 17.08 |
Next Year | NA | 13.80 | 8.00 |
Last 5 Years | NA | 5.90 | 8.10 |
Next 5 Years | NA | 22.10 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -5.88 |
Price/Book (MRQ) | 1.12 | 1.73 |
Price/Cash Flow (MRFY) | NA | 8.52 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -1,027.46% | -19.76% |
Return on Equity (TTM) | -113.75% | -75.03% |
Debt to Equity (MRQ) | NA | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.